Naeem D. Khan

Effect of Medication Co-payment Vouchers on P2Y₁₂ Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction

Tracy Y. Wang, Lisa A. Kaltenbach, Christopher P. Cannon et al. · JAMA · 2019 · 90 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association

Robert A. Gabbay, Debbie Kendall, Christine Beebe et al. · Clinical Diabetes · 2020 · 88 citations · Full text

Medicine, Chronic Disease Control, Health Policy +17

Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention

Joseph Sweeny, Dominick J. Angiolillo, Francesco Franchi et al. · Journal of the American Heart Association · 2017 · 38 citations · Full text

Medicine, Cardiology, Pharmacology +17

Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction

Jennifer A. Rymer, Eileen Fonseca, Durgesh Bhandary et al. · Journal of the American Heart Association · 2020 · 38 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +15

New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims)

Kamil F. Faridi, Narinder Bhalla, Nipun Atreja et al. · The American Journal of Cardiology · 2021 · 20 citations · Full text

Medicine, Cardiology, Internal Medicine +12